Related Experiment Video
Updated: May 15, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
Published on: August 18, 2023
Questions concerning the clinical translation of cell-based interventions under an innovation pathway
1Berman Institute of Bioethics, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract:
Stem cell-based innovation is one pathway to clinical translation that stands in contrast to clinical research and medical treatment. After reviewing recently issued guidelines for responsible innovation, this article examines the potential benefits and harms of using this pathway as well as practical barriers and conceptual concerns regarding it.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Clinical Trials: Overview
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Gene Therapy
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

